✦ LIBER ✦

Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A

✍ Scribed by Kevin Spencer

Book ID: 111160242
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 66 KB
Volume: 108
Category: Article
ISSN: 1470-0328
DOI: 10.1111/j.1471-0528.2001.00244.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First trimester screening for Down's syn

First trimester screening for Down's syndrome using maternal serum PAPP-A and free β=hCG in combination with fetal nuchal translucency thickness

✍ Roberto Biagiotti; Laura Brizn; Enrico Periti; Albertino D'Agata; Ermanno VanZi; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

First trimester prenatal diagnosis of tr

First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A

✍ Kevin Spencer; Kypros H. Nicolaides 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

First-trimester screening for Down syndr

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test

✍ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an

The influence of fetal sex in screening

The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Y. T. Ong; Adolfo W. J. Liao; Demetres Papademetriou; Kypr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 3 views

In a study of 2923 normal pregnancies and 203 pregnancies affected by trisomy 21 we have shown a signi®cant difference in the median MoM of the markers: fetal nuchal translucency, maternal serum free b-hCG and PAPP-A in the presence of a female fetus compared with a male fetus. For maternal serum fr